Philippe Moreau
Impact in
- Hematology top 0.01%
- Multiple Myeloma Research and Treatments
- Oncology top 0.05%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 740
- Multiple Myeloma Research and Treatments 667
- Hematopoietic Stem Cell Transplantation 74
-
- Protein Degradation and Inhibitors 236
- Co-authors
- Jean‐Luc Harousseau (100 shared papers)Thierry Façon (171 shared papers)Hervé Avet‐Loiseau (140 shared papers)Michel Attal (128 shared papers)Jesús F. San Miguel (118 shared papers)Cyrille Touzeau (131 shared papers)Meletios Α. Dimopoulos (152 shared papers)Paul G. Richardson (99 shared papers)
- Journals
- Blood (235 papers)Journal of Clinical Oncology (142 papers)Leukemia (33 papers)Haematologica (30 papers)HemaSphere (27 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Philippe Moreau
894 papers receiving 29.4k citations
Philippe Moreau's Hit Papers
Peers
Comparison fields: 5 of 167
- Hematology 18.7k
- Oncology 11.4k
- Genetics 3.3k
- Molecular Biology 14.9k
- Pathology and Forensic Medicine 2.7k
Countries citing papers authored by Philippe Moreau
This map shows the geographic impact of Philippe Moreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Moreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Moreau more than expected).
Fields of papers citing papers by Philippe Moreau
This network shows the impact of papers produced by Philippe Moreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Moreau. The network helps show where Philippe Moreau may publish in the future.
Co-authors
The 25 scholars most cited alongside Philippe Moreau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 938 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis Hit paper breakdown → | 2005 | 999 |
| 2 | Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study Hit paper breakdown → | 2011 | 663 |
| 3 | Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2017 | 525 |
| 4 | Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† Hit paper breakdown → | 2021 | 491 |
| 5 | 1997 | 452 | |
| 6 | 2006 | 450 | |
| 7 | Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis Hit paper breakdown → | 2017 | 402 |
| 8 | 2012 | 386 | |
| 9 | 2010 | 383 | |
| 10 | 2002 | 380 | |
| 11 | Chemotherapy‐driven dysbiosis in the intestinal microbiome Hit paper breakdown → | 2015 | 376 |
| 12 | Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma Hit paper breakdown → | 2018 | 372 |
| 13 | 2007 | 332 | |
| 14 | 2010 | 302 | |
| 15 | 2017 | 284 | |
| 16 | 2005 | 273 | |
| 17 | 2008 | 270 | |
| 18 | 2009 | 268 | |
| 19 | Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial Hit paper breakdown → | 2020 | 266 |
| 20 | 2006 | 242 |
About Philippe Moreau
Philippe Moreau is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Pathology and Forensic Medicine, having authored 938 papers that have together received 30.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (667 papers), Protein Degradation and Inhibitors (236 papers), Peptidase Inhibition and Analysis (143 papers), Cancer Treatment and Pharmacology (132 papers), Chronic Lymphocytic Leukemia Research (100 papers), Monoclonal and Polyclonal Antibodies Research (78 papers), Hematopoietic Stem Cell Transplantation (74 papers) and Lymphoma Diagnosis and Treatment (58 papers). The work is most often cited by research in Hematology (18.7k citations), Oncology (11.4k citations), Genetics (3.3k citations), Molecular Biology (14.9k citations) and Pathology and Forensic Medicine (2.7k citations). Philippe Moreau has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Jean‐Luc Harousseau, Thierry Façon, Hervé Avet‐Loiseau, Michel Attal, Jesús F. San Miguel, Cyrille Touzeau, Meletios Α. Dimopoulos, Paul G. Richardson, Régis Bataille and Xavier Leleu. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, Haematologica and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.